Guidance for Newly Released COVID-19 Coding

Diagnosing COVID-19: Effective April 1, 2020

  • U07.1 COVID-19 with laboratory confirmation
  • U07.2 COVID-19 without laboratory confirmation

Prior to April 1, 2020, the following ICD-10 diagnosis code may be used

  • B34.2 Coronavirus, unspecified

Testing for COVID-19

New HCPC codes for billing Medicare COVID-19 testing: Effective 4/1/2020

  • U0001Centers for Disease Control and Prevention (CDC) 2019 Novel Coronavirus Real Time RT-PCR Diagnostic
  • U0002 – 2019-nCoV Coronavirus, SARS-CoV-2/2019-nCoV (COVID-19), any technique, multiple types or subtypes (includes all targets)

CPT Code for billing other payors: posted 3/13/2020 – Effective immediately

  • 87635Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique
    • Download the CPT Assistant Guide Fact Sheet (PDF) for coding guidance for the SARS-CoV-2 (COVID-19) test in relation to the use of the new CPT code. The fact sheet includes:
      • Code, descriptor and purpose
      • A clinical example
      • Description of the procedure
      • FAQs

Treating COVID-19

New injection HCPC codes for treating COVID-19 – Effective 4/1/2020

  • C9053 – Injection, crizanlizumab-tmca, 1mg
  • C9056 – Injection, givosiran, 0.5 mg
  • C9057 – Injection, cetirizine HCI, 1mg
  • C9058 – Injection, pegfilgrastim-bmez, biosimilar, (Ziextenzo) 0.5 mg

About Author

Healthcentric Advisors
As the New England Quality Payment Program Support Center, Healthcentric Advisors assists New England-based physician and other eligible clinical practices to prepare for and participate in the new Quality Payment Program (QPP), established by the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA).